Real-world observational study to investigate the tolerability of Gardasil in Californian females.

Trial Profile

Real-world observational study to investigate the tolerability of Gardasil in Californian females.

Not stated
Phase of Trial: Phase IV

Latest Information Update: 11 May 2011

At a glance

  • Drugs Human papillomavirus vaccine recombinant quadrivalent Merck (Primary)
  • Indications Cervical cancer; Human papillomavirus infections
  • Focus Therapeutic Use
  • Sponsors Merck & Co
  • Most Recent Events

    • 11 May 2011 New trial record
    • 09 May 2011 Results were reported at the European Research Organization on Genital Infection and Neoplasia (EUROGIN).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top